Redefining Macrophage Heterogeneity in Atherosclerosis: A Focus on Possible Therapeutic Implications
Comprehensive Physiology · 2025-04 · 15 (2)
DOI: 10.1002/cph4.70008 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Comprehensive Physiology, online erschienen am 19.03.2025. Verfasst von Babunageswararao Kanuri und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Section of Cardiovascular Diseases, University of Oklahoma Health Sciences Center (OUHSC), Oklahoma City, Oklahoma, …. Hauptthemen laut MEDLINE: Atherosclerosis, Macrophages. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 256 Literaturangaben. Gefördert von: NHLBI NIH HHS, American Heart Association, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Atherosclerosis is a lipid disorder where modified lipids (especially oxidized LDL) induce macrophage foam cell formation in the aorta. Its pathogenesis involves a continuum of persistent inflammation accompanied by dysregulated anti‐inflammatory responses. Changes in the immune cell status due to differences in the lesional microenvironment are crucial in terms of plaque development, its progression, and plaque rupture. Ly6C hi monocytes generated through both medullary and extramedullary cascades act as one of the major sources of plaque macrophages and thereby foam cells. Both monocytes and monocyte‐derived macrophages also participate in pathological events in atherosclerosis‐associated multiple organ systems through inter‐organ communications. For years, macrophage phenotypes M1 and M2 have been shown to perpetuate inflammatory and resolution responses; nevertheless, such a dualistic classification is too simplistic and contains severe drawbacks. As the lesion microenvironment is enriched with multiple mediators that possess the ability to activate macrophages to diverse phenotypes, it is obvious that such cells should demonstrate substantial heterogeneity. Considerable research in this regard has indicated the presence of additional macrophage phenotypes that are exclusive to atherosclerotic plaques, namely Mox, M4, Mhem, and M(Hb) type. Furthermore, although the concept of macrophage clusters has come to the fore in recent years with the evolution of high‐dimensional techniques, classifications based on such ‘OMICS’ approaches require extensive functional validation as well as metabolic phenotyping. Bearing this in mind, the current review provides an overview of the status of different macrophage populations and their role during atherosclerosis and also outlines possible therapeutic implications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Internal Medicine, Section of Cardiovascular Diseases, University of Oklahoma Health Sciences Center (OUHSC), Oklahoma City, Oklahoma, USA.
- Centre for Cardio-Metabolic Research in Africa (CARMA), Division of Medical Physiology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
- Division of Immunometabolism, Baker Heart and Diabetes Institute, Melbourne, Australia.
ORCID-Profile: Prabhakara R Nagareddy
Förderung
- NHLBI NIH HHS
- American Heart Association
- National Heart, Lung, and Blood Institute
Zitieren
APA
Kanuri, B., Maremanda, K. P., Chattopadhyay, D., Essop, M. F., Lee, M. K. S., Murphy, A. J., & Nagareddy, P. R. (2025). Redefining Macrophage Heterogeneity in Atherosclerosis: A Focus on Possible Therapeutic Implications. Comprehensive Physiology, 15(2). https://doi.org/10.1002/cph4.70008
Vancouver
Kanuri B, Maremanda KP, Chattopadhyay D, Essop MF, Lee MKS, Murphy AJ, et al. Redefining Macrophage Heterogeneity in Atherosclerosis: A Focus on Possible Therapeutic Implications. Comprehensive Physiology. 2025;15(2). doi:10.1002/cph4.70008
BibTeX
@article{Kanuri2025,
author = {Kanuri, Babunageswararao and Maremanda, Krishna P and Chattopadhyay, Dipanjan and Essop, M Faadiel and Lee, Man Kit Sam and Murphy, Andrew J and Nagareddy, Prabhakara R},
title = {Redefining Macrophage Heterogeneity in Atherosclerosis: A Focus on Possible Therapeutic Implications},
journal = {Comprehensive Physiology},
year = {2025},
volume = {15},
number = {2},
doi = {10.1002/cph4.70008}
}
EUVIMED